SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 139.83 |
Enterprise Value ($M) | 97.71 |
Book Value ($M) | 134.49 |
Book Value / Share | 1.41 |
Price / Book | 1.04 |
NCAV ($M) | 25.00 |
NCAV / Share | 0.26 |
Price / NCAV | 5.59 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.90 |
Return on Assets (ROA) | -0.82 |
Return on Equity (ROE) | -1.31 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.45 |
Current Ratio | 1.87 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 172.47 |
Assets | 281.96 |
Liabilities | 147.47 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 152.07 |
Operating Income | 30.11 |
Net Income | -331.94 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 49.60 |
Cash from Investing | 3.10 |
Cash from Financing | -44.20 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock Inc. | 1.50 | -78.92 | |
13G/A | Continental General Insurance Co | 0.00 | -100.00 | |
13G/A | Armistice Capital, Llc | 6.13 | ||
13G | Nantahala Capital Management, LLC | 8.00 | ||
13G | Vanguard Group Inc | 5.15 | -5.32 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
261,366 | 1,548,010 | 16.88 | |
192,276 | 1,578,235 | 12.18 | |
125,481 | 873,959 | 14.36 | |
119,862 | 827,469 | 14.49 | |
119,610 | 607,044 | 19.70 | |
(click for more detail) |
Similar Companies | |
---|---|
APVO – Aptevo Therapeutics Inc. | ARTL – Artelo Biosciences, Inc. |
ASNS – Actelis Networks, Inc. | ATNF – 180 Life Sciences Corp. |
ATOS – Atossa Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io